The paucity of biological material has inhibited identifying genes that are differentially expressed during mammalian oogenesis and preimplantation development. We report here the linear amplification of mRNA from small numbers of mouse oocytes and preimplantation embryos to generate amounts of sense RNA that are sufficient for suppression subtractive hybridization. The resulting oocyte-specific and 8-cell-specific cDNA libraries were partially characterized, and the known oocyte-specific ZP1, ZP2, GDF-9, BMP15, and H1 oo genes were found in the oocyte-specific cDNA library but not in the 8-cell-specific library. Further characterization of the subtracted oocyte and 8-cell embryo cDNA libraries should furnish a trove of information regarding temporal changes in gene expression during oogenesis and preimplantation development in the mouse.
INTRODUCTION
The first major developmental transition that occurs following fertilization is the maternal-to-zygotic transition in which the embryonic developmental program initially directed by maternally inherited proteins and transcripts is replaced by a new program as a consequence of the expression of new genes [1] . In the preimplantation mouse embryo, detection of transcripts capable of being translated (i.e., functional transcripts) is clearly evident by the 2-cell stage. The maternal-to-zygotic transition has at least three functions that are required for continued development. The first function is to destroy oocyte-specific transcripts, such as the RNA-binding protein MSY2 [2] and histone H1 oo [3] , that are not subsequently expressed. The destruction of these mRNAs restricts the period of time in which these genes can function. The second function is to replace maternal transcripts that are also degraded during oocyte maturation and following fertilization and that are common to the oocyte and early embryo (e.g., actin) with zygotic transcripts. If these maternal transcripts are not 1 Supported by a grant from the NIH to R.M.S. (HD 22681). F.Z. was supported by a training grant from the NIH (T32 HD07516). Portions of this work are being submitted by F.Z. in partial fulfillment of the Ph.D. requirements at the University of Pennsylvania. replenished, development will shortly arrest due to the embryo's inability to execute basic cellular functions. Expression of these genes does not result in reprogramming of gene expression in the classical sense, but their expression is nonetheless essential. The third function of the maternal-to-zygotic transition is to promote the dramatic reprogramming in the pattern of gene expression that is coupled with the generation of novel transcripts not expressed in the oocyte [4] . This reprogramming of gene expression is likely to be the molecular underpinning for the transformation of the differentiated oocyte into the totipotent, 2-cell-stage blastomeres.
The molecular basis for genome activation is now better understood. For example, genome activation, which is accompanied by a change in promoter utilization such that TATA-less promoters are more efficiently used [5, 6] , appears to be relatively promiscuous (i.e., genes whose promoters are accessible to the transcription machinery are expressed) [7] . Superimposed on genome activation is the development of a chromatin-mediated, transcriptionally repressive state [1] that would reduce the expression of inappropriate genes but permit the continued expression of genes that are regulated by strong promoters/enhancers. The expression of these genes would, therefore, be critical for continued development.
The identity of embryo-specific genes (i.e., genes that are not expressed in the oocyte or whose expression is markedly up-regulated compared to the oocyte) is very poorly defined. Although efforts have been made to identify these genes, the methods employed to date have major drawbacks. For example, mRNA differential display is labor intensive, has a high degree of false positives, and is biased toward detecting more abundant transcripts [7] . Likewise, analysis of cDNA libraries derived from oocytes and preimplantation embryos is only as robust as the quality of the libraries, in which rare transcripts may be underrepresented [8] . Last, subtraction methods employed to date are also biased toward detecting abundant transcripts [9] .
Suppression subtractive hybridization (SSH) [10] provides an attractive solution to identify embryo-specific (and oocyte-specific) genes and, in particular, rare transcripts that may encode regulatory proteins; see Diatchenko et al. [10] for an excellent discussion of SSH. The advantage of this method stems from its ability to normalize the mRNA population so that abundant mRNAs are reduced while rare transcripts are enriched. The disadvantage is that the amounts of starting mRNA required for the hybridization are not readily obtained from mouse oocytes/embryos. For example, SSH requires approximately 2 g of mRNA, and this amount would require 25 000 oocytes (80 pg mRNA/oocyte) [11] .
We describe here a method in which small amounts of mRNA from mouse oocytes and preimplantation embryos are amplified linearly to generate sufficient amounts of material to conduct SSH. Using both forward and reverse subtraction protocols, oocyte-and 8-cell-specific transcripts were identified.
MATERIALS AND METHODS

Messenger RNA Preparation and Sense RNA Amplification
The mRNA samples were prepared from a minimum of 100 fully grown, germinal vesicle-intact oocytes as well as 2-cell and 8-cell preimplantation embryos as previously described [7] using the Micro-FastTrack 2.0 mRNA extraction kit (Invitrogen, Carlsbad, CA) according to the manufacturer's instructions. Oocytes were obtained from CF-1 female mice, and embryos were obtained from CF-1 females mated to B6D2F1/ J males. The mRNA was also isolated from adult heart.
First-strand cDNA synthesis was carried out by incubating 3.5 l of mRNA (0.5-14 ng) with 0.5 l (10 M) of cDNA synthesis primer (Table 1) at 70ЊC for 2 min; 0.5 ng of mRNA corresponds to approximately six oocytes. A reverse transcription (RT) reaction (total volume, 10 l) was then prepared with the above mRNA/primer mix in 50 mM Tris-HCl (pH 8.3), 75 mM KCl, 6 mM MgCl 2 , 2 mM dithiothreitol (DTT), 1 mM of each dNTPs, 20 U of RNase inhibitor, and 0.5 M T7-GGG primer. Two hundred units of Superscript II (Invitrogen) were added, and the samples were incubated at 42ЊC for 1 h. This RT reaction also results in dC tailing. Double-stranded cDNA was generated by combining the 10 l of first-strand cDNA sample with 10 l of 10ϫ Advantage 2 polymerase chain reaction (PCR) buffer (Clontech, Palo Alto, CA), 0.2 mM of each dNTPs, 2 U of RNase H (Promega, Madison, WI), and 2 l of 50ϫ Advantage 2 polymerase mix (Clontech) in a total reaction volume of 100 l. Following an incubation at 37ЊC for 3 min to degrade the mRNA template, second-strand synthesis was then performed (95ЊC for 2 min and then 72ЊC for 20 min), followed by two cycles of PCR with the following conditions: 95ЊC for 30 sec and then annealing/ extension at 72ЊC for 15 min.
Before sense RNA (sRNA) amplification, the successful synthesis of double-stranded cDNA was first established by PCR analysis using 1 l of the resulting double-stranded cDNA and the flanking primer 5Ј T7 PCR primer (Fig. 1, black rectangle) and 3Ј PCR primer (Fig. 1 , open rectan- 
FIG. 2.
Size distribution of sRNA made following amplification of oocyte and 8-cell embryo RNA. The material was generated as described in Figure 1 , except during the linear amplification step using T7 RNA polymerase, [␣- 32 P]CTP was present. The samples were then resolved by gel electrophoresis and the size distribution of the sRNA detected by autoradiography. Lanes 1 and 2: amplified sRNA from 8-cell embryos and oocytes, respectively; lanes 3 and 4: amplified sRNA from 8-cell embryos and oocytes, respectively, following spin-column chromatography.
FIG. 3. A)
Size distribution of cDNA generated from dT-primed and random hexamer-primed sRNA. B) Detection of G3PDH in the cDNA preparations by RT-PCR using gene-specific primers. Twenty-five cycles of PCR were performed using the following parameters: 94ЊC for 10 sec, 60ЊC for 30 sec, and 68ЊC for 2.5 min. The resulting material was then run on a 2% agarose gel. The amount of cDNA ST and cDNA SR used for PCR amplification was equal to the amount of single-stranded cDNA generated from sRNA amplified from 20 pg of original mRNA starting material (i.e., 0.25 ϫ the amount of mRNA in a single oocyte).
gle). The size distribution of the resulting material was then assessed by electrophoresis in 1.2% (w/v) agarose gel containing ethidium bromide. In addition, 1 l of the double-stand cDNA was used to detect specific transcript using gene-specific primers (e.g., for glyceraldehyde-3-phosphate dehydrogenase [G3PDH]). Preparations that displayed a broad size range and contained specific transcripts were further processed as follows:
The remainder of the double-stranded cDNA was phenol/chloroform extracted, ethanol precipitated, and resuspended in 20 l of diethyl pyrocarbonate (DEPC)-treated water. Ten microliters of the sample were dropdialyzed on a 0.25-m Millipore filter (Millipore Corporation, Bedford, MA) [12] against 50 ml of DEPC-treated water for a duration of 4 h to overnight to remove unincorporated nucleotides and excess salts.
For sRNA amplification, the purified double-stranded cDNA template was incubated at 37ЊC for 4 h in 40 mM Tris-HCl (pH 7.5) con- original mRNA assuming 80 pg mRNA/oocyte and 14 pg mRNA/8-cell embryo and an overall recovery rate of 90% of the initially isolated mRNA. To generate radiolabeled sRNA, the same conditions were used as above, except 30-60 Ci of [␣-32 P]CTP (3000 Ci/mmol; 10 mCi/ ml; Amersham, Biosciences, Piscataway, NJ) were added. The size distribution of the radiolabeled products was determined by electrophoresis in a 1.2% denaturing agarose gel and autoradiography. Nonradiolabeled and radiolabeled sRNA were then purified on Chromospin-100 columns (Clontech). The amount of sRNA generated was determined by RiboGreen staining (Molecular Probes, Eugene, OR) according to the manufacturer's instructions. The amount of radiolabeled sRNA was quantified by trichloroacetic acid (TCA) precipitation.
Sense RNA Characterization
To establish the suitability of the sRNA for conversion to cDNA that would be used for SSH or microarray analysis, RT was performed with purified oocyte sRNA with either an oligo-dT primer (Table 1) or random hexamers. One-fortieth (1/40) of the Chromospin-purified sRNA (see above) was added to 0.5 l of dT primer (10 M) or 0.5 l of random hexamer (10 M). The sample was incubated for 3 min at 70ЊC and then combined with first-strand buffer (50 mM Tris-HCl [pH 8.3], 75 mM KCl, and 3 mM MgCl 2 ); 5 mM DTT; 1 mM each of dATP, dGTP, and dTTP; 12 M dCTP; 1 M of [␣-32 P]dCTP; 40 U of RNasin; and 300 U of Superscript II in a total volume of 10 l. When the random hexamers were used, the sample was initially incubated at room temperature for 10 min. In both cases, RT was conducted at 42ЊC for 90 min. The RNA strand in the cDNA was then degraded by incubating the sample at 37ЊC for 30 min with 4 U of RNase H. Following phenol extraction, first-strand radiolabeled cDNA was subjected to electrophoresis in a 1.2% agarose gel and size distribution visualized with a Storm imaging system (Amersham Biosciences).
To assay for the presence of a specific transcript, nonradiolabeled cDNA was prepared as described above, except radiolabeled dCTP was replaced with 1 mM dCTP. One-tenth (1/10) of the nonradiolabeled cDNA primed with dT (cDNA ST ) or random hexamer (cDNA SR ) was used for PCR using gene-specific primers.
Suppression Subtractive Hybridization
Suppression subtractive hybridization was conducted with 2 g of purified 8-cell and oocyte sRNA. The cDNA synthesis and subtraction were performed with the PCR-select cDNA subtraction kit (Clontech) according to manufacturer's instructions, except the mRNA was replaced by amplified sRNA.
Eight-cell transcript-enriched subtracted cDNA and oocyte transcript-enriched subtracted cDNA were generated by forward and reverse SSH. These subtracted cDNAs were cloned into a TA vector (Invitrogen) to generate an 8-cell-and an oocyte-subtracted cDNA library, respectively. Differential screening was carried out using the PCR-select differential screening kit (Clontech) according to the manufacturer's protocol. The PCR products of randomly selected clones were then alkaline denatured and spotted onto a nylon membrane in two replicates that were then hybridized with radiolabeled probes generated from the 8-cell and oocyte cDNA subtracted probes. The relative extent of differential expression of each clone was estimated by calculating the ratio of the signal with the homologous subtracted probe to that with the heterologous subtracted probe. The clones for which the ratio was Ͼ5 were sequenced, and these sequences were then used for a BLAST search against GenBank database after RepeatMasker (http://ftp.genome.washington.edu/RM/RepeatMasker.html) and Contig Assembly Program (http://www.infobiogen.fr/sevices/analyseq/ cgi-bin/cap in.pl) were used to identify redundant clones.
PCR and RT-PCR of Selected Genes of Interest
Selected genes identified by SSH were used for PCR and RT-PCR to validate their differential expression. To confirm the presence of the oocyte-specific histone H1 gene (H1 oo ), PCR was performed using the 8-cell subtracted and oocyte subtracted cDNA with H1 oo gene-specific primers (Table 1 ). The PCR (25 cycles) was performed as follows: 94ЊC for 30 sec, 55ЊC for 30 sec, and 72ЊC for 1 min.
The differential expression of several other candidate genes revealed from the sequencing analysis was also confirmed by PCR as above using gene-specific primers (Table 1 ). The PCR conditions were the same as those used for H1 oo , except 28 cycles were used for Kim-1 and 35 cycles for all other genes.
To confirm the differential expression of selected transcripts detected after SSH, RT-PCR using total RNA isolated from equal numbers of oocytes and 8-cell embryos was also conducted. The isolated RNA was reversed transcribed using an oligo-dT primer, and five oocyte/embryo equivalents were used for RT-PCR as previously described [13] using 30 cycles and the aforementioned PCR conditions. The radiolabeled PCR products were run on an 8% acrylamide gel that was imaged with a Storm imaging system.
cDNA libraries. A) Randomly picked clones from 8-cell-specific cDNA library screened with 8-cell-specific probe. B) Randomly picked clones from 8-cell-specific cDNA library screened with oocyte-specific probe. C) Randomly picked clones from oocyte-specific cDNA library screened with oocyte-specific probe. D) Randomly picked clones from oocytespecific cDNA library screened with 8-cell-specific probe. An example of an 8-cell-specific gene would be clone A3, and an example of an oocyte-specific gene would be clone B1.
FIG. 6. Differential expression of oocyte-and 8-cell-specific genes in cDNA libraries and oocytes and 8-cell embryos. A) Equal amounts of the oocyte-and 8-cell-specific libraries were subjected to RT-PCR using genespecific primers. Shown is an ethidium bromide-stained gel. B) RNA was isolated from equal numbers of oocytes and 8-cell embryos and subjected to RT-PCR using gene-specific primers. The experiment was conducted at least three times for each gene. Shown is an autoradiogram of a representative experiment. Rabbit ␤-globin mRNA (0.125 pg/oocyte-embryo) was added before RNA isolation. The globin mRNA serves as an internal standard for the efficiency of the RT-PCR reactions [13] .
RESULTS AND DISCUSSION
Linear Amplification to Generate sRNA
To obtain the amounts of mRNA required for SSH (2 g), we developed an amplification scheme to generate sRNA from small numbers of oocytes/embryos (Fig. 1) . The method couples the Eberwine linear RNA amplification procedure [12] with Clontech's SMART technology to select for long-length cDNAs. Following RT, dC-tailing, template switching and extension, and second-strand cDNA synthesis, two rounds of PCR amplification were performed before sRNA amplification. The rationale for the PCR step was to provide enough starting material for the linear amplification step, which results in an approximately 2000-fold amplification, to generate sufficient amounts of material for SSH without the need for reamplification. Our concern was that reamplification could distort the representation of the original mRNA population, whereas two rounds of PCR before linear amplification would not.
The size distribution of the resulting radiolabeled material from either oocytes or 8-cell embryos before and after purification ranged from 0.5 to 12 kilobases (kb) (Fig. 2) . The amplification was reproducible, and a similar size distribution was also observed for 2-cell embryos and adult heart tissue (data not shown). The procedure was optimized for starting with as little as 0.5 ng of mRNA, which corresponds to approximately six oocytes. The extent of amplification was routinely found to be 4000-to 8000-fold, as determined by either TCA precipitation of the radiolabeled sRNA or by RiboGreen fluorescence, and generated microgram amounts of sRNA from the original mRNA sample that were sufficient for SSH.
To establish that the sRNA generated from the linear amplification procedure could serve as a template for cDNA synthesis and contained bona fide sequences present in the original mRNA population, sRNA was first reverse transcribed with either the poly dT primer (cDNA ST ) or random hexamers (cDNA SR ). As a result, cDNA ST and cDNA SR with a size distribution from 0.5 to 12 kb (Fig.  3A) was generated; the size distribution was similar to that of the original sRNA. The presence of known genes in the cDNA population was confirmed by PCR amplification of the cDNA ST and cDNA SR with gene-specific primers for G3PDH (Fig. 3B) . The presence of several other genes (Hdac2, Mos, Plat, and Sin3a) was also readily detected using gene-specific primers (data not shown).
SSH to Identify Genes Differentially Expressed in Mouse Oocytes and 8-Cell Embryos
We elected to use 8-cell rather than 2-cell embryos for SSH for the following reasons: First, genome activation during the 2-cell stage appears to be a relatively promiscuous process [7] . Thus, transiently and inappropriately ex- a The ratio is obtained from the differential screen of the oocyte versus 8-cell clones. b The BLAST identity was defined as the best hit from either the NR (nonredundant) or EST (expressed sequence tag) database. c Multiple clones were found that corresponded to different regions of the same gene. Figure 4 . The average insert size of randomly picked clones was approximately 600 base pairs (data not shown), which is consistent with the average size generated by the Rsa I step in the SSH protocol. Following SSH, the resulting subtracted 8-cell and oocyte cDNAs were used to construct 8-cell and oocyte subtracted libraries, respectively. These resulting libraries would contain what are termed oocyte-and embryo-specific transcripts, whereas in actuality, most of them contain genes that are differentially expressed (as opposed to an all-or-none expression profile). Accordingly, a differential screening of randomly picked clones was performed (Fig.  5) . Candidate genes that were differentially expressed were sequenced and then subjected to a BLAST search in GenBank (Tables 2 and 3) . Detection of the oocyte-specific ZP1, ZP2, GDF-9, BMP15, and H1 oo transcripts [3, 14] in the oocyte subtracted library increased confidence in the validity of the subtraction procedure. In addition, many novel genes (i.e., clones whose sequences are not present in the existing databases) were detected in both the oocyteand 8-cell-specific cDNA libraries (data not shown).
To confirm the differential expression pattern in the subtracted population for both the oocyte and embryo subtracted libraries, PCR of the subtracted cDNA was performed with gene-specific primers. As anticipated, the oocyte-specific histone H1 oo gene was not present in the subtracted 8-cell library but was readily detected in the subtracted oocyte library (Fig. 6A) . Likewise, Oas15, Bpgm, and two other unknown genes (3E4 and 3H3) that were preferentially expressed in the oocyte subtracted library (Table 1) were also detected in the oocyte, but not in the embryo, subtracted library. Reciprocally, the Kim-1 and Zmpste24 genes that were preferentially expressed in the 8-cell embryo (Table 2) were also readily detected in the 8-cell, but not in the oocyte, subtracted library (Fig. 6A) . Final validation of the method was achieved by assaying with RT-PCR the relative level of expression of Zmpste24, Bpgm, and two unknown oocyte-specific genes (3E4 and 3E6) in oocytes and 8-cell embryos (Fig. 6B) . Results of these experiments documented the preferential expression of Bpgm, 3E4, and 3E6 in the oocyte and of Zmpste24 in the 8-cell embryo.
The intrinsic strengths of SSH are, first, that the only underlying assumption is that genes are differentially expressed and, second, that the normalization procedure enhances the ability to detect rare transcripts that potentially encode regulatory proteins. The inherent strength of microarray analysis is that it permits analysis of global patterns of gene expression, but it is limited by the quality of the cDNA library used to generate the array (e.g., rare transcripts may not be arrayed). The method we describe here to amplify linearly and reproducibly mRNA from mouse oocytes and preimplantation embryos generates sufficient amounts of material for SSH (to identify oocyte-and embryo-specific genes), and preliminary results indicate that it is also suitable for microarray analysis of gene expression (unpublished results). Combining these two complementary approaches, coupled with further characterization of the subtracted oocyte and 8-cell embryo cDNA libraries, should furnish a trove of information regarding temporal changes in gene expression during gametogenesis and preimplantation development in the mouse.
